HM
Hemagen Diagnostics, Inc.
HMGN · OTC
$0.00 +0.00% (+$0.00)
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
39 /100
Moderate Beta 0.36x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre HMGN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
William Hales
Employees
15
Headquarters
Columbia